Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Brazilian Pharmaceutical Market Outlook 2017-2027

This image opens in the lightbox

News provided by

Visiongain Ltd

30 Aug, 2017, 13:01 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, August 30, 2017 /PRNewswire/ --

Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies

The Brazilian Pharmaceutical market was valued at $26.40bn in 2016. Visiongain forecasts this market to increase at a CAGR of 7.6% in the first half of the forecast period. Originator drugs held the largest market share in 2016, this trend however will change in the second half of the forecast period where we predicted that Generic drugs will take over the lead.

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

How this report will benefit you: 
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 181-page report you will receive 107 charts - all unavailable elsewhere.

The 181-page report provides clear detailed insight into the Brazilian Pharmaceutical market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope 

• Brazilian Pharmaceutical Market forecasts from 2017-2027

• Brazilian Pharmaceutical Market forecasts from 2017-2027, by segment:
• Originator Drugs
• Generic Drugs
• OTC

• Brazilian Pharmaceutical Market forecasts from 2017-2027, by therapeutic area:
• CNS
• Cardiovascular
• Gastrointestinal/Metabolic
• Oncology
• Infectious Disease

• Leading Domestic Companies in the Brazilian Pharmaceutical Market:
• EMS
• Hypermarcas
• Medley
• Eurofarma
• Aché
• Cristalia
• Teuto
• Libbs
• Biolab
• União Química

• Leading Multinational Companies in the Brazilian Pharmaceutical Market:
• Novartis
• Sanofi
• Roche
• Merck & Co.
• Pfizer
• Takeda
• Bayer
• GlaxoSmithKline
• Boehringer Ingelheim
• Astra Zeneca

• SWOT and STEP Analysis of the Brazilian Pharmaceutical market

• This report also discusses:
• The Brazilian healthcare environment, covering important institutional bodies and agencies, surveying the regulatory system, analyzing the balance between public and private healthcare provision and looking at the wholesale and distribution landscape
• Regional variations within Brazil, with profiles of each region and an analysis of their healthcare challenges and opportunities
• Brazilian Biologics Market, which includes qualitative and quantitative analysis.

Visiongain's study is intended for anyone requiring commercial analyses for the Brazilian Pharmaceutical market and the leading companies competing in that country. You find data, trends and predictions.

Buy our report today Brazilian Pharmaceutical Market Outlook 2017-2027: Originator, Generic, OTC, CNS, Cardiovascular, Gastrointestinal, Metabolic, Oncology, Infectious Diseases, Domestic Manufacturers and International Drug Companies.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1972/Brazilian-Pharmaceutical-Market-Outlook-2017-2027

List of Companies Mentioned in the Report 

Abbott Laboratories

Aché Laboratórios Farmacêuticos S.A

Actavis PLC

Agila Specialties Private Ltd

Allianz Saúde

Alteogen Inc

AmerisourceBergen Corporation (ABC)

Amgen Inc

Antaris Consulting

Astellas Pharma Inc

AstraZeneca PLC

Athos Farma SA

Axis Biotec Brasil

Baxter International Inc

Bayer AG

Bergamo Ltda

Beth Israel Hospital

Billi Farmacêutica

Biocad

BiocadBrazil Farmaceutica

Biocon Limited

Biolab Emcure Farmaceutica Comercial Ltda

Biolab Farmaceutica

Bio-Manguinhos (Instituta de Tecnologia em Imunobiologicos)

Biomm SA

Bionovis SA

Biovail Corporation

Boehringer Ingelheim GmbH

Boiron

Brainfarma Indústria Química e Farmacêutica

Brasil Pharma

Brazil Produtos Roche Químicos e Farmacêuticos

Bristol-Myers Squibb (BMS)

BTG Pactual

Bunker Industria Farmaceutica

Butantan Institute

Câmara de Regulação do Mercado de Medicamentos (CMED)

Care Plus Medicina Assistencial S/S Ltda

Ceitec SA

Celesio AG

Chemo Group

Claris Lifesciences Ltd

Conselho Federal de Farmácia

Conselho Federal de Medicina (CFM)

Corporacion Infarmasa SA

Cosmed Industria de Cosmeticos e Medicamentos

Cristália

CVS Pharmacy

Daiichi Sankyo

Delta

Dimed SA

Distribuidora Farmacêutica Panarello Ltda

DM Industria Farmacêutica Ltda

Drogaria Sao Paulo

Drogarias DPSP SA

Drogarias Farmais

Drogarias Pacheco

Drogarias Tamoio

Drogasil SA

Eisai Co Ltd

Eli Lilly & Co

Emcure Pharmaceuticals Ltd

Empresas Andromaco

EMS

Eurofarma

Eurofarma Argentine

Eurofarma Chile

Eurofarma Uruguay

Everis Group

F. Hoffmann-La Roche AG

Farmácia Ben

Farmácia Popular

Farmacias Mais Econômica

Farmácias Guararapes

Farmalife

Farmanguinhos (Instituto de Tecnologia em Farmacos)

Farmindustria SA

Federação Nacional de Saúde Suplementar (FenaSaúde)

Forest Laboratories Inc

Fundação Oswaldo Cruz (FioCruz)

Fundação Ezequiel Dias (Funed)

Genzyme Corporation

Germed Pharma

Gilead Sciences Inc

GlaxoSmithKline PLC (GSK)

Glenmark Pharmaceuticals

Golden Cross

Grünenthal Group

Grupo Amil Saúde

Grupo Bradesco Saúde

Grupo Cimed

Grupo Notre Dame Intermédica Saúde

Grupo SulAmérica Saúde

Hapvida Assistência Médica

Health Canada

Hebron

Hemobrás

Horizon Pharma PLC

Hypermarcas

IMA Laboratories

Indar Institute

Indian Council of Medical Research

Innova Pharma

Janssen

Johnson & Johnson

Kantar Health

Laboratório Daudt Oliveira

Laboratório Farmacȇutico do Estado de Pernambuco (LAFEPE)

Laboratório Prata

Laboratório Sanobiol

Laboratório Teuto

Laboratorio Volta

Laboratório Tiaraju

Laboratórios Gautier

Laboratórios Klinger Do Brasil

Laboratorios Laprin S.A

Lazard

Legrand Pharma Industria Farmaceutica Ltda

Libbs Biotec

Libbs Farmacêutica Ltda

Luper Indústria Farmacêutica

mAbxience

Mantecorp Quimica Industria e Farmaceutica Ltda

Médecins sans Frontières (MSF)

Medley Farmacêutica

Meizler Biopharma SA

Melcon Indústria Farmacêutica SA

Merck & Co., Inc

Merck KGaA

Merck Serono

Mercosur

Merial

Merz  Pharma GmbH & Co. KGaA

Metlife Exclusivamente Odontológicos

Metropolitan Life Insurance Company

Minas Gerais State Department of Health

Moksha8

Multilab Industria e Comerci de Produtos Farma

Mundipharma International Ltd

Mylan NV

Nature's Plus Farmacêutica Ltda

NeoQuimica

Nortis Farmaceutica Ltda

Novartis AG

Novartis Biociências

Novo Nordisk A/S

Nycomed

OdontoPrev

Omint Serviços de Saúde

Oncoprod

Optimer Pharmaceuticals Inc

Orygen  Biotecnologia

Otsuka Pharmaceutical Co Ltd

Panpharma

Pasteur Institute

Pele Nova Biotecnologia SA

Pfizer Inc

PharmaPraxis

Porto Seguro - Seguro Saúde

Probiomed SA de CV

Probiotica Laboratórios Ltda

Procter and Gamble Co

Profarma

Profarma Specialty SA

Protalix BioTherapeutics Inc

Quesada Farmacêutica SA

Quintiles Inc

Raia Drogasil

Raia SA

Ranbaxy Laboratories Ltd

Reckitt Benckiser Group PLC

Roche Diagnostica Brasil

Rosário

Sabin Vaccine Institute

Sandoz Brazil

Sandoz do Brasil Indústria Farmacêutica

Sanofi

Sanofi Pasteur SA

Sant'Ana S.A. Drogaria Farmácias

Santa Cruz Distribuidora de Medicamentos

Savicevic Participacoes SA

SC Participações Empresariais Ltda

Schwarz Pharma

Serum Therapeutic Institute

Shasun Pharmaceuticals Ltd

Sinclair IS Pharma PLC

Sindusfarma

State Pharmaceutical Laboratory of Pernambuco (LAFEPE)

Strides Arcolab

Sun Pharmaceutical Industries Ltd

Supera Farma Laboratorios

Takeda Pharmaceutical Company Ltd

Telefônica Digital

Teva Pharmaceutical Industries Ltd

The Walgreen Company

TKS Farmacêutica Ltda

Torrent Pharmaceuticals Ltd

UCB Pharma SA

União Química Farmacêutica Nacional SA

Valeant Pharmaceuticals International Inc

Warc

Watson Pharmaceuticals Inc

Wockhardt Ltd

Yasuda Marítima Saúde Seguros SA

Zydus Cadila

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.